2018

CCM Duopharma Maintains Positive Results For Q3 FY 2018

Kuala Lumpur – CCM Duopharma Biotech Berhad (CCM Duopharma) grew its Revenue by 7.69 per cent to RM383.09 million from RM355.73 million for the first nine months of its financial year ended September 30, 2018. The Company’s Profit Before Tax (PBT) for the period under review rose 7.80 per cent to RM42.01 million from RM38.97 million.

High quality, internationally proven biosimilar diabetic therapy BASALOG ONE® OFFERS CONVENIENT AND LOWER COST TREATMENT FOR DIABETES PATIENTS

Kuala Lumpur November 27, 2018 – High quality, internationally proven biosimilar diabetic therapy that is cost effective can effectively substitute ‘branded’ innovator drugs in reducing the burden on public health and paying patients to manage the cost of treating diabetes in Malaysia, which has the highest number of diabetics in the Asean region.

CCM Duopharma Makes Equity Invesment in SCM Lifescience of Korea for STEM Cell Technology and Development

INCHEON, SOUTH KOREA, October 25, 2018 – CCM Duopharma Biotech Berhad (“CCM Duopharma” or the “Company”) and SCM Lifescience Co., Ltd. (“SCM Lifescience”) of Korea today announced that they have entered into a share subscription agreement (“SSA”) whereby CCM Duopharma acquired common shares and redeemable preference convertible shares in SCM Lifescience upon and subject to the terms and conditions set out in the SSA.

Architect Wins ‘Flavettes Glowing Star Search

Petaling Jaya August 29, 2018 – Che Norashikin Ahmad Azmi, 25, an architect from Kuala Lumpur, was crowned as the winner of the ‘Flavettes Glowing Star Search’, beating 600 other participants, at an event held here recently. Organised by CCM Pharmaceuticals Sdn Bhd, the beauty contest with a twist was aimed at discovering a talented, charismatic and confident young woman with a vibrant personality and radiant look, to become the next ambassador of its leading product, ‘Flavettes Glow”.

CCM Duopharma Pays Out Higher Dividend Based on Improved Revenue and Profit Performances For H1 2018

Kuala Lumpur – CCM Duopharma Biotech Berhad (CCM Duopharma) grew its Revenue by 7.03 per cent to RM257.25 million from RM240.36 for the first half of its financial year ended June 30, 2018.

CCM Duopharma Launches ‘SHE WEEK’ to Push Best Practices On Occupational Health and Safety

Leading pharmaceutical company equips employees with knowledge and skills on safety, health and environment for safer and healthier workplace

KUALA LUMPUR AUGUST 14, 2018 – In line with its commitment to ensuring safe and environmental-friendly working conditions for its employees, CCM Duopharma Biotech Berhad (CCM Duopharma) recently launched a Safety, Health and Environment (SHE) Week to inculcate the SHE culture in the Company’s daily operations.
Besides creating greater awareness of promoting environmental, health and safety best practices amongst employees, CCM Duopharma’s SHE Week aimed at increasing the workforce’s continuous engagement and commitment to safety excellence at the workplace.

Speaking at the launch of the SHE Week, CCM Duopharma Biotech Berhad Group Managing Director, Leonard Ariff Abdul Shatar said that SHE management is crucial to not only prevent accidents at the workplace but also to provide a conducive working environment that will inevitably boost productivity and employee morale which will lead to greater company success.

“We operate in the pharmaceutical industry that emphasises the importance of the safety of our products and their impacts on our customers and the environment. Implementing a strong and effective SHE management system is essential in the handling of machineries and equipment, and careful management of chemicals and biological substances in the laboratory as well as the production process. A healthier and safer working environment significantly helps to prevent workplace mishaps and enable us to realise our zero accident goal,” he said. Leonard Ariff added that the workplace is like a second home to majority of Malaysians, hence the importance of nurturing a safe, supportive and sustainable working environment.

“Workplace health and safety not only cover the physical well-being of employees but also their mental health. Exposure to various workplace hazards can lead to work-related stress which if left untreated can transform to psychological conditions or physical illnesses. Our employees are the heart of our success. Hence, CCM Duopharma is committed to safeguarding the mental well-being of our workforce and our SHE management system strives to cultivate a positive work culture to keep our employees happy and productive with the ability to create high-quality work,” said Leonard Ariff.

The CCM Duopharma SHE Week was launched by the Minister of Human Resources, YB Tuan M. Kulasegaran who commended the Company for its effort to educate and increase awareness of its employees on the importance of advocating the highest degree of physical, mental and social well-being at the workplace. “Complying with SHE regulations enables an organisation to drive progress across all operations.

A company can establish a sustainable working environment by identifying potential hazards and improving operational safety. As a result, employees will perform better and acquire relevant skills to significantly contribute to long-term success. I applaud CCM Duopharma’s SHE initiatives as they will create well-trained employees to meet the country’s demand for skilled workers in embracing global challenges,” said YB Tuan M. Kulasegaran.

Various activities were held during the SHE Week including quizzes, competitions, talks and the set up of exhibition booths on the responsibilities, benefits and best practices of SHE at the workplace. CCM Duopharma is currently the largest current Good Manufacturing Practice (cGMP) –

Pharmaceutical certified manufacturer in Malaysia with facilities in Bangi, Klang and Glenmarie. This standard ensures all production activities in the plants are in line with the standards established by Malaysia’s Health Ministry’s cGMP and international standards.

CCM Duopharma Celebrates Aidilfitri as One

SHAH ALAM – This year’s Hari Raya Aidilfitri is extra special for the 1,142 CCM Duopharma Biotech Berhad (CCM Duopharma)’s employees attending the Company’s recent ‘Majlis Riang Ria Aidilfitri’ as it was the first time they celebrated the joyous occasion together as one big family at a single venue and on the same day. Held at a hotel in Shah Alam, the event was held in two successive sessions due to the big turnout which showcased CCM Duopharma’s spirit of togetherness on a bigger scale.

Inspiring Charity and Kindness During Ramadan

Kuala Lumpur – Ramadan is a month of solidarity and Muslims in Malaysia take the opportunity to increase the amount of charitable acts during this period to help the less fortunate and underprivileged who may not get to experience the joy of the holy month.

Ramadan Cheer for 32 Underprivileged Children CCM Duopharma fetes children of Rumah Titian Kasih Al-Inayah to a Buka Puasa Treat

Kuala Langat JUNE 6, 2018 – Ramadan is a time for good deeds and helping out the less fortunate. While most children in Malaysia celebrate the holy month with their family and friends, let us remember and help the underprivileged children who do not have the opportunity to enjoy the blessings of Ramadan with their loved ones. In the true spirit of Ramadan, CCM Duopharma Biotech Berhad (CCM Duopharma) recently hosted 32 underprivileged children of Rumah Titian Kasih Al-Inayah, aged between six and 17, to a buka puasa session to spread the joy of the holy month.

CCM Duopharma Gets Nod for Bonus Issues and Pangen Acquisition

SHAH ALAM MAY 31, 2018 – Shareholders of CCM Duopharma Biotech Berhad (CCM Duopharma) at its Extraordinary General Meeting (EGM) today approved the resolution to credit 371,945,333 new ordinary shares as fully paid-up on the basis of four bonus shares for every three existing CCM Duopharma shares and also a dividend reinvestment plan (DRP) which provide the shareholders with an option to reinvest their cash dividend in the Group’s shares.